Chemical formula: C₁₉H₂₄N₂O₄  Molecular mass: 344.174 g/mol  PubChem compound: 3083544

Therapeutic indications

Arformoterol is indicated for:

Bronchoconstriction in patients with chronic obstructive pulmonary disease

Population group: only adults (18 years old or older)

Arformoterol is indicated for the long-term, twice daily (morning and evening) maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

For this indication, competent medicine agencies globally authorize below treatments (click for details):


Arformoterol is contraindicated in the following cases:


Airway hyperreactivity

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.